Stephen Taub Premium Perceptive Advisors Poised to Benefit from Biopharma IPO The health care-focused hedge fund firm plans to add to its stake when Kodiak Sciences goes public next week. Stephen Taub September 26, 2018 Joseph Edelman, chief executive officer of Perceptive Advisors (Chris Goodney/Bloomberg)